R&D 5 changes underway for R&D IT shifting to advanced modalitie... Back in 2000, the FDA approved only six biologics versus 27 new molecular entities (NMEs).
News Moderna builds commercial muscle as new launches loom Moderna expands its commercial team, as FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
